MRVI
Maravai LifeSciences Holdings, Inc.Marquee-fund ownership over time
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies | Q3 2024(8Q snapshot) | 7Q | $8.54 | $4.08 | -52% |
| Citadel Advisors re-entered | Q3 2024(8Q snapshot) | 7Q | $8.22 | $4.08 | -50% |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $8.22 | $4.08 | -50% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $8.22 | $4.08 | -50% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $8.22 | $4.08 | -50% |
| Point72 Asset Management re-entered | Q3 2024(8Q snapshot) | 7Q | $8.22 | $4.08 | -50% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| D.E. Shaw | Q3 2024 | Q1 2025 | → $4.20 | -49% |
| Maverick Capital | Q2 2023 | Q3 2023 | → $10 | -33% |
| D1 Capital Partners 2× in & out | Q3 2021 | Q1 2022 | → $30 | -46% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at MARAVAI LIFESCIENCES HOLDINGS, INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from May 28, 2026 — the most recent Form 4 on file — not from today.
- Form 4/Aamend0001251299-26-000003May 28, 2026
- Form 40001829810-26-000001May 28, 2026
- Form 40001833453-26-000004May 28, 2026
- Form 40001262930-26-000001May 28, 2026
- Form 40001210525-26-000001May 28, 2026
- Form 40001251299-26-000001May 28, 2026
- Form 40001829753-26-000001May 28, 2026
- Form 40001403373-26-000005May 28, 2026
- Form 40001684273-26-000005May 22, 2026
- Form 40001832579-26-000005May 22, 2026
- Form 40001684273-26-000003Mar 17, 2026
- Form 40001832579-26-000003Mar 17, 2026
- Form 40001684273-26-000001Jan 20, 2026
- Form 40001832579-26-000001Jan 20, 2026
- Form 40001251299-25-000004Dec 9, 2025
Fundamentals
XBRL · Maravai LifeSciences Holdings, Inc.Annual figures sourced directly from Maravai LifeSciences Holdings, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for MARAVAI LIFESCIENCES HOLDINGS, INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventJun 3, 2026
- 8-KMaterial eventMay 29, 2026
- 10-QQuarterly reportMay 8, 2026
- 8-KMaterial eventMay 7, 2026
- DEF 14AProxy statementApr 24, 2026
- 10-KAnnual reportFeb 26, 2026
- 8-KMaterial eventFeb 25, 2026
- 10-QQuarterly reportNov 7, 2025
- 8-KMaterial eventNov 6, 2025
- 8-KMaterial eventOct 27, 2025
- 10-QQuarterly reportAug 11, 2025
- 8-KMaterial eventAug 11, 2025
- 8-KMaterial eventJul 18, 2025
- 8-KMaterial eventJun 25, 2025
- 8-KMaterial eventJun 9, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Point72 Asset Management | Q4 2025 | open | $3.64 | $4.08 | +12% |
| Citadel Advisors | Q1 2025 | open | $4.20 | $4.08 | -3% |
| Citadel Advisors | Q3 2024 | Q4 2024 | $8.22 | $5.20 | -37% |
| Two Sigma Investments | Q3 2024 | open | $8.22 | $4.08 | -50% |
| D.E. Shaw | Q3 2024 | Q1 2025 | $8.22 | $4.20 | -49% |
| AQR Capital Management | Q3 2024 | open | $8.22 | $4.08 | -50% |
| Millennium Management | Q3 2024 | open | $8.22 | $4.08 | -50% |
| Point72 Asset Management | Q3 2024 | Q1 2025 | $8.22 | $4.20 | -49% |
| Renaissance Technologies | Q3 2024 | open | $8.54 | $4.08 | -52% |
| Maverick Capital | Q2 2023 | Q3 2023 | $15 | $10 | -33% |
| D1 Capital Partners | Q3 2021 | Q1 2022 | $55 | $30 | -46% |
| D1 Capital Partners | Q1 2021 | Q2 2021 | $36 | $38 | +6% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.